DEC 12, 2018 7:00 AM EST

Expanding Biobanking Size and Scope to Advance Big Data Discovery

Sponsored by: Brooks Life Sciences
Speaker
  • Associate Staff in Dermatopathology, Cleveland Clinic Medical Director, Central Biorepository, Cleveland Clinic
    Biography
      Dr. Ko is the Medical Director of the Cleveland Clinic Central Biorepository housed within Pathology and Laboratory Medicine at the Cleveland Clinic in Cleveland, Ohio. She is also a Dermatopathologist with an interest in melanoma, Merkel cell carcinoma, and tumor immunology. She completed her BS/MD in the 6-year program at Northeast Ohio Medical University. She then completed an Internship at Cleveland Clinic in Internal Medicine, and a PhD in Immunology at Case Western Reserve University. She is boarded in Anatomic and Clinical Pathology and Dermatopathology, and received all of her training at the Cleveland Clinic.

    Abstract
    DATE:   December 12, 2018
    TIME:    07:00am PST, 10:00am EST
     
    Currently, the Cleveland Clinic Biorepository is an assembly of several biobanks together with the Lerner Research Institute. Excel spreadsheets track almost everything – and there are no universal LIS, SOPs, universal, centralized freezer monitoring, or means to electronically track patient tissue.
     
    The Cleveland Clinic is embarking on an enterprise-wide initiative to accelerate its biobanking capacity, leveraging its clinical volume and disease expertise. As part of this initiative, the Cleveland Clinic is partnering with Brooks Life Sciences to build a state of the art, 21,000 square-foot structure biobanking facility, set to open in the summer of 2019.
     
    The collaboration will partner with the community of Cleveland to advance personalized medicine for an array of conditions, and support research with clinically annotated human tissue samples. It will accelerate translational research through streamlined patient recruitment and enrollment, standardized samples processing, and centralized storage, and allow Cleveland Clinic experts and their collaborators to investigate and cure the diseases that ail our patients.
     
    In this webinar you will learn:
    • What clinical translational specimens do we have that could contribute to big data discovery?
    • What resources do you need to build an infrastructure to enhance researchers’ study of human tissue samples and advance personalized medicine for an array of conditions?
     
     

    Show Resources
    You May Also Like
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    DEC 15, 2020 10:00 AM PST
    C.E. CREDITS
    DEC 15, 2020 10:00 AM PST
    DATE: December 15, 2020 TIME: 10:00am PST Scientists from Thermo Fisher Scientific will walk us through the world of microorganisms. They will discuss their most recent research on viruses,...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    DEC 12, 2018 7:00 AM EST

    Expanding Biobanking Size and Scope to Advance Big Data Discovery

    Sponsored by: Brooks Life Sciences

    Specialty

    Cancer Research

    Molecular Biology

    Genetics

    Biotechnology

    Clinical Research

    Clinical Diagnostics

    Cell Biology

    Laboratory Testing

    Biomarkers

    Dna

    Molecular Diagnostics

    Medicine

    Diagnostics

    Genomics

    Biochemistry

    Geography

    North America68%

    Europe15%

    Asia9%

    South America3%

    Africa3%

    Oceania1%

    Registration Source

    Website Visitors55%

    Email Promotions28%

    WAVE Newsletter Promotion5%

    Social Media Promotions1%

    Trending Newsletter Promotion1%

    Website Banners1%

    Other9%

    Job Title

    Facility/Department Manager17%

    Executive17%

    Research Scientist12%

    Lab Management10%

    Medical Laboratory Technician8%

    Student8%

    Educator/Faculty6%

    Clinical Laboratory Scientist6%

    Scientist5%

    Medical Doctor/Specialist4%

    Veterinarian2%

    Microbiologist2%

    Marketing/Sales1%

    QC/QA1%

    Chemist1%

    Organization

    Academic Institution21%

    Hospital16%

    Biotech Company10%

    Research Institute8%

    Clinical Laboratory7%

    Life Science Company5%

    Government5%

    Medical School3%

    Medical Center3%

    Pharmaceutical Company2%

    Contract Research Organization (Cro)2%

    Non-Profit Organization2%

    Industrial Company1%

    Medical Device Company1%

    Other4%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more